Searched for
GV PRASAD
- Frequent FDA inspections slow down Indian pharma exports, says GV PrasadGV Prasad, Chairman, CII National Committee on Pharmaceuticals said that everybody should up their game in terms of quality, systems, disci...18 Nov, 2019, 05.09 PM IST
DRL Q1 profit surges 45% YoY to Rs 663 crore; margins shrink 400 bpsAnalysts in an ET Now poll had anticipated Rs 481 crore profit.29 Jul, 2019, 04.24 PM IST- Can't say if the Teva deal is low-value, will take 2 months to get FTC clearance: GV Prasad, Dr Reddy’s LabsPrasad said that the company will bring in some interesting deals in proprietary product areas where the capital leverage is high.13 Jun, 2016, 07.21 AM IST
- We will make efforts to get money back from Venezuela: GV Prasad, Dr Reddy'sGV Prasad of Dr Reddy's said that the company will engage with the Venezuela government to get the money back at the official exchange rate.13 May, 2016, 12.25 PM IST
- Dr Reddy's Q3 net profit rises marginally to Rs 579 croreNet income from sales and services rose to Rs 3,967.9 crore for Q3 as compared to Rs 3,843.1 crore during the same period of previous fisca...10 Feb, 2016, 11.23 AM IST
- Dr Reddy's submits response to USFDA over warning letterDr Reddy's Laboratories has submitted a response to the US health regulator on a warning letter it had received last month.08 Dec, 2015, 09.31 PM IST
- Dr Reddy's Lab Q2 net rises 26% to Rs 722 croreSaumen Chakraborty, chief financial officer of Dr Reddy’s said, despite headwinds from a few segments, the company did well during the quar...30 Oct, 2015, 04.36 AM IST
- Dr Reddy's Laboratories to enter Japanese market through a partnerPharmaceutical major Dr Reddy's Laboratories today said it has plans to enter Japanese market through partnerships for specific products.12 May, 2015, 08.48 PM IST
- Dr Reddy’s chief GV Prasad bemoans bureaucracy in companyDr Reddy’s Labs has not fully utilised its potential and must break the barriers of bureaucracy within the organisation, chairman of the co...25 Dec, 2013, 07.45 PM IST
- Ranbaxy saga has opened eyes of companies: GV Prasad, Dr Reddy’s LaboratoriesAs a company, we have always focussed heavily on improving quality systems, training, approach towards regulatory compliance.10 Jul, 2013, 10.31 AM IST
- Dr Reddy's promoters transfer large holding to family-owned TrustThe promoters of pharmaceutical firm Dr Reddy's Laboratories have transferred shares from Dr Reddy's Holdings Limited (DRHL) to APS Trust, ...27 Jul, 2012, 10.23 AM IST
- Blocking buyouts by MNCs misplaced nationalism: GV Prasad, Dr Reddy's LaboratoriesAny effort to put hurdles in the way of foreign drug firms buying Indian companies is 'misplaced nationalism,' GV Prasad, vice-chairman and...19 Jul, 2012, 11.17 AM IST
- Dr Reddy's targeting five percentage points above market growth: GV PrasadDr Reddy's is targeting to grow at least five percentage points above the market growth and hopes to reach the goal over 18 months from now.12 May, 2012, 05.59 PM IST
- SEBI exempts Dr Reddy's promoters from open offerSEBI has exempted the promoters of Dr Reddy's from makingan open offer on account of transfer of nearly a fourth of co's equity holding amo...08 May, 2012, 12.23 PM IST
- Expect to see double-digit growth in next fiscal: GV Prasad, Dr Reddy Laboratories Ltd.He said that the company was focussed on the 5 top markets of India, Russia, US, UK and Germany and was looking at deepening its presence i...18 Apr, 2011, 12.18 PM IST
- No Indian co is a tier-I pharma player: GV Prasad, Dr Reddy'sIn a candid conversation, Dr Reddy’s Laboratories’ vice-chairman and MD, GV Prasad, talks about the strengths and weaknesses of the domesti...21 Sep, 2010, 04.46 AM IST
- Palepu quits company boardDr Reddy's Lab on Tuesday said Krishna G Palepu has resigned as independent director on the company's board. Mr Palepu was also a member of...21 Jan, 2009, 12.58 AM IST
Load More- Frequent FDA inspections slow down Indian pharma exports, says GV Prasad
